The Prostacyclin Analogue, Treprostinil, Used in the Treatment of Pulmonary Arterial Hypertension, is a Potent Antagonist of TREK-1 and TREK-2 Potassium Channels
Kevin P. Cunningham(King's College London), Emma L. Veale(Medway School of Pharmacy), Alistair Mathie(University of Westminster), Lucie H. Clapp(The London College)
Cited by 7
Related Papers
Guide to Receptors and Channels (GRAC), 5th edition
|British Journal of Pharmacology|2011|1.9k
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors
|British Journal of Pharmacology|2019|712
Guide to Receptors and Channels (GRAC), 3rd edition
|British Journal of Pharmacology|2008|508
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes
|British Journal of Pharmacology|2019|505
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488